China: HiRO acquires Courante Oncology CRO in US

Harvest Integrated Research Organization (HiRO), a China-based global CRO, has acquired Courante Oncology, a US-based full-service clinical research provider specializing in oncology product development. Courante Oncology brings over 25 years of drug development experience with expertise that spans all aspects of phase 1-3 clinical trials, ranging from initial feasibility studies and protocol development to site…

You must be a HMI Subscriber to view this content.

Subscribe Now »